U.S. Stem Cell, Inc. 4
4 · U.S. Stem Cell, Inc. · Filed Sep 23, 2016
Insider Transaction Report
Form 4
U.S. Stem Cell, Inc.BHRT.OB
Borman Mark P
Director
Transactions
- Award
Stock Option (right to buy)
2016-09-19+1,500,000→ 1,502,810 totalExercise: $0.02From: 2016-09-19Exp: 2026-09-19→ Common Stock (1,500,000 underlying)
Holdings
- 24(indirect: By Trust)
Common Stock